세계의 폭식장애 시장 : 제품, 최종 사용자, 유통 채널별 예측(2025-2030년)

The Binge Eating Disorder Market was valued at USD 556.42 million in 2023, expected to reach USD 587.85 million in 2024, and is projected to grow at a CAGR of 5.98%, to USD 835.76 million by 2030.

Binge Eating Disorder (BED) is characterized by recurrent episodes of eating large quantities of food, often quickly and to the point of discomfort, accompanied by a feeling of loss of control. BED is distinct as it involves no compensatory behaviors (e.g., purging), diverging from other eating disorders. The necessity for understanding BED's market stems from its growing recognition as a critical mental health issue with significant physical health implications, necessitating effective treatments, therapies, and interventions. Pharmaceuticals, psycho-social therapies, and nutritional treatments are primary applications, providing a broad scope for end-use among healthcare providers, clinics, and rehabilitation centers. The market growth is influenced by increasing awareness, improved diagnostic prevalence rates, and the rising funding and research initiatives by governmental bodies and health organizations. Notably, the North American and European regions lead in market expansion due to advanced healthcare systems and proactive measures against mental health disorders. Opportunities lie in increased telemedicine services, the development of novel therapies, and personalized medicine approaches, relying on genetic and phenotypic cues to tailor interventions. Companies can capitalize on these by investing in digital health applications and cutting-edge pharmaceuticals. Nevertheless, challenges persist in the form of societal stigma, inadequate insurance coverage, and a lack of awareness in some demographics, which hinder market penetration and treatment adoption. Limitations also arise from regulatory hurdles and the high cost of research and development in pharmaceuticals. However, these barriers spark potential innovation areas, such as digital behavioral intervention platforms, which can increase accessibility and cost-effectiveness, and AI-driven diagnostic tools. The market is integrative by nature, emphasizing a multidisciplinary approach-merging psychiatry, nutrition, and technology-which paves the way for cross-industry collaborations to fuel business growth in emerging therapeutic landscape opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Binge Eating Disorder Market

The Binge Eating Disorder Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing public health campaigns and education efforts around binge eating disorder
  • Rising healthcare expenditure and insurance coverage for mental health services
  • Increasing focus on personalized, patient-centered approaches to BED treatment
• Market Restraints
  • High cost associated with binge eating disorder treatments
• Market Opportunities
  • Emergence and integration of digital health solutions for binge eating disorder treatments
  • Growing partnerships between healthcare providers, researchers, and advocacy groups for BED treatment and awareness
• Market Challenges
  • Stigma and lack of awareness about binge eating disorder treatments

Porter's Five Forces: A Strategic Tool for Navigating the Binge Eating Disorder Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Binge Eating Disorder Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Binge Eating Disorder Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Binge Eating Disorder Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Binge Eating Disorder Market

A detailed market share analysis in the Binge Eating Disorder Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Binge Eating Disorder Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Binge Eating Disorder Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Binge Eating Disorder Market

A strategic analysis of the Binge Eating Disorder Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Binge Eating Disorder Market, highlighting leading vendors and their innovative profiles. These include Alsana, Inc., Alvogen, Amneal Pharmaceuticals, Inc., Apotex Inc., Ascent Pharmaceuticals, Inc., BALANCE Eating Disorder Treatment Center, Carolina House Eating Disorder Treatment Center, Center for Change, Eating Disorders Treatment Center, Eating Recovery Center, Equip Health Medical, P.C., Hikma Pharmaceuticals PLC, Mallinckrodt PLC, Monte Nido & Affiliates Holdings, LLC, Montecatini Eating Disorder Treatment Center, Natural Food Therapy, Red Oak Recovery, Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, TalktoAngel, The London Centre for Eating Disorders and Body Image Ltd., Timberline Knolls Residential Treatment Center, Veritas Collaborative, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Binge Eating Disorder Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Diagnostics and Treatments. The Treatments is further studied across Medications and Psychotherapy. The Medications is further studied across Anticonvulsant and Antidepressants. The Psychotherapy is further studied across Cognitive Behavioral Therapy, Dialectical Behavior Therapy, and Interpersonal Psychotherapy.
• Based on End-User, market is studied across Hospitals, Online Therapy Platforms, Specialty Clinics, and Support Groups.
• Based on Distribution Channels, market is studied across Hospitals Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing public health campaigns and education efforts around binge eating disorder
    • 5.1.1.2. Rising healthcare expenditure and insurance coverage for mental health services
    • 5.1.1.3. Increasing focus on personalized, patient-centered approaches to BED treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with binge eating disorder treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence and integration of digital health solutions for binge eating disorder treatments
    • 5.1.3.2. Growing partnerships between healthcare providers, researchers, and advocacy groups for BED treatment and awareness
  • 5.1.4. Challenges
    • 5.1.4.1. Stigma and lack of awareness about binge eating disorder treatments
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Need for efficient diagnosis to accurately identify BED and any comorbid conditions
  • 5.2.2. End-User: Higher preferences for hospitals with comprehensive services, essential for addressing the complex needs of BED patients
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Binge Eating Disorder Market, by Product

• 6.1. Introduction
• 6.2. Diagnostics
• 6.3. Treatments
  • 6.3.1. Medications
    • 6.3.1.1. Anticonvulsant
    • 6.3.1.2. Antidepressants
  • 6.3.2. Psychotherapy
    • 6.3.2.1. Cognitive Behavioral Therapy
    • 6.3.2.2. Dialectical Behavior Therapy
    • 6.3.2.3. Interpersonal Psychotherapy

7. Binge Eating Disorder Market, by End-User

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Online Therapy Platforms
• 7.4. Specialty Clinics
• 7.5. Support Groups

8. Binge Eating Disorder Market, by Distribution Channels

• 8.1. Introduction
• 8.2. Hospitals Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Americas Binge Eating Disorder Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Binge Eating Disorder Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Binge Eating Disorder Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. EDCare expands eating disorder treatment with virtual intensive outpatient programs in Colorado, Kansas, and Nebraska, improving accessibility and flexibility for long-term recovery
  • 12.3.2. Axsome Therapeutics' Phase 3 trial of Solriamfetol aims to address binge eating disorder in US adults, potentially securing FDA approval
  • 12.3.3. Monte Nido & Affiliates Expands Eating Disorder Treatment with New Day Treatment Location in Houston
  • 12.3.4. Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner Ecosystem
  • 12.3.5. InsideOut Institute's USD 8 Million Funding Enhances Support for Eating Disorders
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alsana, Inc.
• 2. Alvogen
• 3. Amneal Pharmaceuticals, Inc.
• 4. Apotex Inc.
• 5. Ascent Pharmaceuticals, Inc.
• 6. BALANCE Eating Disorder Treatment Center
• 7. Carolina House Eating Disorder Treatment Center
• 8. Center for Change
• 9. Eating Disorders Treatment Center
• 10. Eating Recovery Center
• 11. Equip Health Medical, P.C.
• 12. Hikma Pharmaceuticals PLC
• 13. Mallinckrodt PLC
• 14. Monte Nido & Affiliates Holdings, LLC
• 15. Montecatini Eating Disorder Treatment Center
• 16. Natural Food Therapy
• 17. Red Oak Recovery
• 18. Rhodes Pharmaceuticals L.P. by Purdue Pharma L.P.
• 19. Sun Pharmaceutical Industries Ltd.
• 20. Takeda Pharmaceutical Company Limited
• 21. TalktoAngel
• 22. The London Centre for Eating Disorders and Body Image Ltd.
• 23. Timberline Knolls Residential Treatment Center
• 24. Veritas Collaborative
• 25. Viatris Inc.